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Bjrrk.Shilcy 60” Convcxo-Coneavr tilting dir prosthesis 
has rceci*ed much attention i  the medial lilcrsturc and 
genfralcd both mncern and canhrion among palianls and 
physicians. 
Analysis ofcurrent data from the manufacturer, mwctl 
ar a rcvicn of the medical itrrahrc, suggesi, that the 
Mechanical iailurc is a comolicalion of both mcclranical and 
biologtcal artificial hean v&cc. The reports of outlel stun 
fracture of Bjork-Shilcy 60” Convcxo-Concave (BSCCXQI 
YBIVCP. the recall of nonimplanted valves by the manufat- 
lurer (Shiley Incorporated) and the considerable attention 
directed to the problem by news media have rcsulled in 
eonccrn among patients who have received tlae valves and 
their physicians: as well as confusion among a larger number 
of pal~cnlr who have rcccived other models of the Bjurk- 
Shilcy valve or w&c, manufactured by other companies. 
T/w psrposc of /hi.s gnpcr ir m: II describe the events 
leading to the recalls of nonimplanted BSCC-60 valves: 21 
prcscnl current data rcgardmg the incidence of outlet strut 
fracture based on information qplicd by the manufxturcr 
and from a review of published scricb of patients in whom 
this valw has been wed: 31 outline mea~urcs to diagnose 
outlet ~,rilt fracture and describe a plan of managemen, for 
pabents who develop oullct ,Ir”I fracture of the BSCC.60 
valve; and 41 make recommendations for Ihe management of
padenls who have BSCCdO vaive~ implamed. 
Historical Background 
The BjBrk-Shilcy tilling disc valve was Arnt introduced 
inlo clinical use in 1969. Since then, a number of moditica- 
lions have been incolporatcd in the basic design, act, of 
which is detailed in Table I, The BSCC-60 valve was 
designed to decrease thromboembolic omplications and 
WBE placed in clinical use in 1976. Specific changes in design 
from previous models of the Bj6rk-Shiley tilting disc valve 
included: I) making the inlet strut an integral part of the 
orifice ring to improve durability of this strut: 2) moving the 
occluder disc away from the orifice ring in the open position 
to reduce slasis and valve thrombosis; and 3) increasing 
blood flow through the minor Row orifice of the valve to 
improve hrmodynamic performance. 
A later modification was made that permitted a greater 
i70”) opening angle of the occludcr disc. However, this valve 
had bmilcd distribulion in Europe. Australia, South Africa 
and Canada. was not used in the United States and is not 
considered in this report. Tlris report is /i&cd IO I/,, XI’ 
Com~l~xo-Concow prosrlesi~. 
Previous clinical reports OF oullct strut fracture. Reports 
of clinical series using the BSCCdO valve have demon- 
strated beneficial effects of thcsc modifications with regard 
to reducing the incidence of thromhoembolic omplications 
(I-4). However, fracture of the outlet strut with resulting 
cmbolization of the occludcr disc has occurred in a small 
percentage of these prostheses. The tint reported BSCC-M Computewed files crc maintained on all valves shipped 
outlet strut fracture occurred with an sonic wlve wosrheris by the manufacture,. Data are accumulated from implant 
in September 1978 during the initial clinical w&&n (51. &ds that are to he mailed to the company by the imp!&ing 
As of June 14, 1987. there have been rcwrts of 213 outlet surpcon at the time of implantation of the vaivcs. Because 
strut fractures among approximately 83.wO pmsthescs cstt- 450% of rhcse implant cards arc returned. some assump- 
mated to have been tmplanred. Sevcnry-six percent of these tions arc made for purposes of statistical analysis. By 
!,,wtures have occurred in the large (?9. 31 and 33 mm) and companng the dates of implantation indicated on the cards 
24% in the small (21,23,25 and 27 mm) BSCC-60 valves (6). received with the shipping dates for each valve. an empirical 
Anal& of recalled valves bv manufacturer and sub=. distnbuuon of Ice time to imrrlantation is cornouted. This 
qucnt &ms. After the first r&t of BSCC-60 outlet strut 
fracture. the manufacturer undertook engineering and qual- 
ify control analyses and instituted procedures aimed at 
detecting weakness of the outlet strut IO orifice ring welds. 
Of particular note was that in vitro pulse duplicator studies 
usicg extreme opening stresses produced no stmt fractures. 
In May 1980. a load deflection test was added to quality 
control procedures todetect weakness at the weld points. In 
May 1982. the manufacturer ecalled 29. 31 and 33 mm 
BSCC-hlvalves b subject them to the residual stress test. In 
addition. more detailed inspection of tk weld points was 
added to the manufacturit.g process in July 1983. Also in July 
1983. large (29. 31 and 33 mm) BSCC-60 valves manufac- 
tured between February 1981 and March 1982 were recalled 
after a retrospective statistical analysis that indicated d 
hither incidence of outlet strut f,ce:urc for these mostheses. 
‘Further analysis of recalled BSCC-M) valves; as well as 
BSCC-643 vitlvcs recovered from patients after fracture, 
suggested that excessive outlet s& Wcsscs could DCLU, 
during disc &we of some prostheses. although fracture 
had not occurred under these condittons with accclcmted 
cycle testing or in a pulse daplicalor. However. when 
markedly out of tolerance prostheses wcrc submitted to 
extreme closure srresses using a fatigue tester. outler Strut 
fracture was reproduced. Additional refinements in quality 
control were made to assure proper occluder disc to inlet 
strut surface match in March and Aoril 1984. In October 
dl\tnbut!oo is ap&d to all v&es that have b&n shipped 
and establishes an “implantalion” date for each valve. Tha 
effect of death in decreasing the population at risk i$ taken 
into aeeount by superimposing an operarwc mortality rate of 
5% and a late monality that is equivalent !o a 5 yea, swvival 
rate of 80%. These adjustments provide the numbers at risk 
in each mterval of <he life table. Using the number of valve 
failures reported to the company for each postoperative 
interval. actuarial estimates of the proportion of valves iree 
of outlet strut fiac!urc arc determined. Linearized rater arc 
calculated by dividing the number of smut fractuies by the 
total number of patient years. These data have been pro- 
vided periodically by the manilfacturer to physicians (7). 
Strut frarhrre n)!e. In a recent rcwt to the Food and 
Drug Admimstration from the manufxturer (8) the entire 
series of implanted BSCC-60 valves wa setwated into small 
121 to 27 mm) and large (29 to 33 mm) sizesbecause the great 
majority of outlet tnw fractures has occurred in the large 
valves. The large valves were further divided into three 
groups according to the processing date. DitTercnccs /n the 
rate of outlet strut fracture among these four 8,o”pr have 
been observed. 
Table 2 contams the linearized rate of outlet strut frac- 
ture. expressed as cvcnts per IO0 patient-years (or. equiva- 
lently. percent per year, and the actuarial event-free rate at 
5 years for each of these ?our valve gmups. The linearized 
rate is caual to the hazard rate when the risk is constant 
1985. because of further rctrospccti~e statistical analyses through time. The hward rate can alto he evaluated ~a- 
indicaling a higher incidence of outlet strut fracture, 29. 31 rately for each year from the life 12ble (Table 3). For the 
and 33 mm BSCC-60 VBIYCS manufactured from March I,!82 group wtth the highest risk. the hazard xc decreases 
through June 1982 were recalled and further distribution of signiticantly (p = 0.03 (Fig. I). For the other three groups. 
29.31 and 33 mm prostheb-s was halted. In November 1986. the risk of oudetstmI fracture isapproxtmatelyconstant; the
all unimplanted small (2 I, 23.25 and 27 mm) BSCC.60 valves increase m rate during rhc most recent interval for two of 
thehe tbrec groups is based on the occu~~enee of oniy two 
fractu:es in a rclatwcly few number of patients at risk. 
Limitations of analysis of fracture incidence. The method 
ohed by the manuftcrurcr has potential for the introduction 
ofblab. The melhoti ofestimation of lag time to implantation 
assomca Gur vaives ior whwn onptant cards are returned are 
rcprcwnaovc of all implants. which may not be the case. 
The right tail of the datribution is truncated, which con- 
strain\ all YBIYC\ to be “implanted” wilhin 24 months. The 
net rcwlt of there assuroptioos may bean overcatimation of 
the number of valves implanted and therefore at risk. and 
thus an underestimation of the incidence of outlet strut 
fracture. That all outlet strut fractures are not reported to the 
company also results in underestimating the Irile incidence 
and may rcpnxnt the greatest source of error; however, the 
information prowded by rhe mnnufactorer ib vatoable for 
determining aI tbc pattern of outlet stmt fracture through 
time. and b) the relative variation among subgroups based on 
size and mtplant period. 
Actively followed patient series may provide a more 
accurate estimate of the absolute incidence: however, it is 
likely that published reports may overestimate the true 
incidence of oullel ~truf fmcture because the occurrence of 
such events may be partly responsible for the interest in 
reviewing the series and number of patients at risk is 
relatively small at individual centers. 
Of the available reports of BSCC-60 valve series 
11.3.4.W II. five had observed outlet strut fracture in the 
mitral position (Table 4). For the two older series of valves 
implanted before or during 1981, only one fracture was 
reponed for a combined linearized rate of O.OS%/year. In the 
four more recent series of valves implanted since 1980. tb ‘re 
‘were I2 fractures in approximately’I.932 valve-years. for a 
combined linearized rate of 0.62Wwar. 
Five ofthe surgical groups (1.3.4.7.1 I) also reported their 
experience with the aortic valve, and only one group (II) 
observed fractures in the nortic position. The sonic valves 
described by this group were of a special premarket subset 
that were used in only three institutions (Karolinska Insti- 
tute. Deborah Heart and Lung lnstitutc and the University 
of lowa~. Thus. although outlet ~tr”t fractures have been 
reported with the aortic RSCC-M wlve (12.13). the rusk of 
this eveot in the aortic position appears to be extremely 
small for valve sizes 19 through 27 mm. Direct comparison of 
aortic verros mitral valves by size is difficult because most 
sonic valves are of the smaller sizes. 
Swnmnry of Risk Awlysis 
From the data supplied by the manufacturer. iiere IS no 
evidence of WI incrcasing risk of outlet Strom frrtcturc; it 
cxpiant might herecommended. Ifthtrposrihlc link between 
young age and out!% 5,ru, fracture is borne out wtbin the 
next few )ears. the rclatwc wk of wamng to iec if .I” 
~ncreawd nxk exictr should not he cxce~~iue. :a\ shown an 
Ihe rlght hood column in Tobic 4. 
Elective valve explantation. With regard to elechve reap 
:rauon 10 cxplanl unct BSCC-MI valve>. wch opewtion 
would likely have 3 ~5% monalay. If noi corwdcrably 
h@er In addition. the wrvivon might not bc acwred of 
receirine a better prosthesis with regard to other cauw5 of 
valve-related marbtdlty or nwntal;:y. T!w. hssed on the 
data currentlv wadable. elcctw? exolanlaiion of rbe LMrk- 
Shdey 60” Convex”-Concave valvc;,~ not supponcd n-t the 
present tone. EtTons should be directed loward education of 
paoentc and pbycicians in the early rccognmun and diagno- 
qi? of outlet strot fracture and of the value of prompt 
oocrarwc intervention. 
Diagnosis of Outlet Strut Fracture 
Any patient with a erojthetic hart valve who devsloo~ 
acute &&rive hea,L i&n, rhould be suspected of having 
Valve risk group. BSCC-60 valves can be clr&cd into prosthetic valve dfiiiuunction. The key to rucces,fol manap- 
four risk groups based cm size and processing da: mc~ of paderos with BSCC-60 valve outlet ([rut fracture 
A) SmaN sirs wlwes 121 to 27 mm) oppcnr IO kosr n wrv and rewltont disc escape is prompt diagnosis and immediate 
low risk of,Jlrrrc~w (estimated by the manufacturer to be replecement ofthe prosthesis. Of all peiienrs reported 10 the 
0.OZ%lyear) to the maximal observed follow-up of about IO manufacturer with outlet slrut fracture. 36% rurvivcd. Of 33 
years. This is confirmed by clinical reports of aortic valve suc:~ cares reponed in the literature t3.t0.t I.tCN). I5 
series published to date. (68%) of 22 patients who underwent operation curvwd. 
B) Tire /urge sire whes (29 IO 33 nzw procwscd h&.v Clinical diagnosis. Outlet strot fracture of an aortw or 
February 1. 1981 also lwr u low rbl; lO.O5%/warJ. Thi\ is mitral BSCC-60 valve must be suspected in any patient who 
wported by thr available reports of mitral valve series complains of sudden onzct of rapidly progresive dyrpnea. 
implanted before 1981 (Table 4). chest oain. amoeirmenl or toss of cooscioowcss or cardiac 
assumed to he a mixture of Groupr A, C and D, have an 
average fracture risk 0. 0.62%/year. 
ldentitication of patienls at greatest risk. There is Ml 
uncertainty regarding the pattern of fracture in time and the 
identification ofpatients who arc at grcntcrt risk. It appcon. 
however. that the risk is tmt increasing with time. If it iz 
decreasing, then the problem may be wlf-coetamed. If the 
risk 1s coos&mt. then mdividualized deetwos by the pa- 
tients physicians would have to be made according to 
particula. patient and valve attributes. Investigation is cur- 
rently underway to explore whether or not a higher ri\k of 
outlet strut fracture is prcxot in young patients. If such a 
risk were the case for young potienrr with B large size mitral 
valve in whom the nsk of explantation may be low and the 
potential gain in cnpcctcd survival might bc high. clcctwc 
arrhyt’hmia lli.lS,. The paem may repon a change or 
absence of prosthetic valve sounds 115). On physical clam- 
inatmn. hypatension. shock and wvcrc pulmonary edema 
ore invariably present. Absence of normal prosthe:lc valve 
xwndr or “clicks” may be noted. although ths may not he 
early dewrmined m B patient wth more than one procthcm 
t14.17). A cardiac mmnur may or may not be prcrcm 
ft4.tj.20). 
Overpnrtratcd chest radiograph Tar diagnosis. The Go- 
& most expeditious study that should be readily obtamablc 
m wrtually zany hospital or emergency treatment center and 
that t) highly effective in making the diagnosis of oullel wol 
fracture i\ an owrprmworcd <iwsr roliopropl!. prrfcruhly ;I! 
,,,<, rirmir Iposteror amerior and lateral or obbque). Lateral 
or obliouc views arc better for viwaliring the strurc 
~tl.IR.?Sl. The radiowapbic appearance of intact and frac- 
tured pratheses is shown in Figures ? and 3. 
Fw 2. Chest radiographs of a palient after sonic and mitral 
valve replacement with Bjbrkihiley 69” Convea~Concave cardiac 
valve ororthcsrs. A. Porteroankrior view. B. Lateral view C. 
Enk&d wcw IO show d,radr of the twu pros,herer. No,e the 
mclalbc anfice ring and slruls as well as Ihe we marker. which is 
emkdded m the occluder dkce. 
cardiac chamber or along the course of the aorta or a major 
syrlcm~ atlery). 3) Presence of the occluder disc in another 
disc (typically overlying a cardiac chamber or along Ihe 
course of rhe aoila). If any of these findings are presenl m 
the clinical setting described, further diagnostic studies are 
rime consming nnd eanwmnry. and will delay proper 
surgical treatmenl. 
In some cases. the melallic structure of the valve may no! 
be easily seen on a chest radiograph because of the tissue 
density of severe pulmonary edema. In such CWZS. emergent 
echocardiography 10 detect the presence or absence of 
normal occlude, disc molion 07), OF Ruoroscopy to demon- 
blrale absence of the occlude, disc and the outlet strut l3lL 
arc useful. For physicians who are not familiar with the 
radiographic appearance of other types of prosthetic heart 
valves. guides have been published (32.33). 
Treatment of Outkt hut Fracture 
hmcdiats operntion. Once Ih< diag”o\ir of outlet P,‘“, 
fracfure and occluder d!vc escape F c\li,hbihed. the pat,ent 
should undergo lmmedmte opcwion Supportive care in- 
cludes the use of rupplcmeoral o .ygcn. cndolracheal intu- 
bation and mecbanrcal veou:~tmo 85 wsll a\ ihe adminwa- 
don of varapressorr and diuretics. bur mmawm of w3 
measures rhow!d not unduly d&a; operaimn. lnvtitutmn of 
partial cardiopu!monary bypass before fnductmn of aocsthc- 
ria may be required for hemodynamic and rcsp~atory ap- 
port (I?). 
Owrative Procedures. The d&claw oraclhe% should bc 
retooked and. replaced. The appropriate cardiac chambers 
sixold he thorouebly examined to idunllfy and remove !he 
frac:ured strat and occiuder disc. part&rly ii there coill. 
ponents were visualized in the hcati in the imtnl radiographs 
(17,181. When these components arc not located in the 
cardiac chambers. they should be removed from the aorta or 
peripheral arteries &her at the live of the cardiac repatr 
(22.24) or ar a kr date when the patienr’s condition ~5 
stable (15.26). Iotraopentive radiograph% may permnt local- 
ization of the components (22). lntraoperative ecbocardiaa- 
why has also been used to Incate metallic foreign bud;e, ,, 
and around cardiac chambers 1341. 
Screening Methods to Determine Patients at 
Risk for Outlet Strut Fracture 
There are currently no wtsitive and sue& methods 
avail able for clinical kxning of pat~eot; with BSCC-60 
valv s that will predict an mcrcased likelihood of outlet st:“! 
frx.are. Metalk& analy~s of explanted valves h:i, re- 
veakd microscopic &nges (?8) and aneduoroccopy may 
detect fracture of one leg of the outlet strut before disruption 
and embolization: however. neither of there method? has 
clinical utility as a screening tool. Unfortunately. echopho- 
nocardiogmphic evaluation of Bjdrk-Shdcy valw in the 
mmal position that can detect major ralve-related comphca- 
dons such ai txivalvular leak and valve ,hrombos,s has no, 
idemikd abrwrmalilir~ of actual audet SINI fracture 135). 
In an attempt to identify YPIV~F that might be prone IO 
strut fatigue and failure after !mplantauon, rhc manufacturer 
has evaluned several methods. Tu dare. none ha\ bren 
reliable in detecting abnormalities indicative of strut fatigue 
or abnormal disc rwwemen~ wggestmg an out of lolcrimcc 
condidon. Digit.4 acoustic rignal snalysn to detect subtle 
changes in the outlet strut of the BSCC-6u wlve ib currently 
being exolored in viiro. but if\ clinial uiiliw rcmainx un- 
proved. 
Reporting Cmsidemtions 
When new rnformut,on hccomc\ .w;i,i;,hle about any 
medical device that iodute\ the powbdity of advcrrc 
performance of that dewce. the manufactaer has a moral 
and crhui obligation 10 inform regulatory agencies. Such 
information mus~als~ be gwen to phyvcians responsible for 
prt~nt* if Ihc magmtudr of the problem warran tt. In the 
Figure 4. Abdominal radiograph showing embolited occluder disc 
in aana (upper arrow) and fractured strut in the Id common iliac 
artery ttowcr arrow). Rcpraluced by perrnirrion from Davis et ai. 
(22). 
case of outlet strut fracture, the manufacturer has circulated 
reports to surgeons who arc known to have implanted 
BSCC-60 valves as well as to the genenl medical commu- 
nity; however. since <50% of implrnt cards supplied with 
BSCC-60 valves have been returned to the manufacturer. the 
dissemination of information to all involved surgeons has 
been hampered. Furthermore. documented adverse perfor- 
~WXIW, particularly the occurrence of outlet strut fracture. 
may not have been reported to the manufacturer. Improved 
methods of communication could provide more precise 
estimaw of bath the number of adverse events as welt as the 
number ofpatienrs at risk and thus improve the accuracy of 
data analysis. 
The dilemma facing the implanfilg surgeon concerns 
information that should be passed on to individual patients. 
On the one hand. there may be a substantial negative 
psychological effect on a patient who receives information 
about a potentml problem of outlet Wut fracture. particu- 
larly when the risk of f&re is low and explantation is not 
believed to bc warranted. On the other hand. a patient armed 
with appropriate information regarding the presenting symp- 
toms of outlet strut fracture may seek medical attention 
promptly and thereby improve the chances of successful 
reop;ration. Physicians and institutions reaponsiblc for pa- 
tients with implanted medical devices should be made aware 
of potential problems and the need for prompt diagnosis and 
trcctme”,. 
Based upon information supplied by Shilcy Incorporated. 
as welt as a review of pertinent literature currently available. 
we conclude thal: 
I) Elective rcoperation and explantslion of the Bj6rk- 
Shiley 60” Convexo-Concave valve p:osthesis in arympto- 
matic patients is not supported. If the risk of outlet strut 
fracture either decreases or remains constant over time, as 
appears to be the case, then the risk of death due to owlet 
strut fracture would be much lower over a 10 year period 
than the risk of elective reoperation. 
2) !f e pz!ient wi!b a well functioning Bjdrk-Shiley 60” 
Convcxo-Concave valve prosthesis requires reoperation for 
another cardiac lesion, explantation could be considered if 
the increased operative risk and risk of valve-related mor- 
bidity and mortality ofthe replacement prosthesis is believed 
to be lower than the risk of valve-related morbidity and 
mortality oithe BSCC-M) valve. 
3) A ~rwarn of physician education should continue so 
that Bj&k-Shilcy 6@ &nvexo-Concave va!vc outlet strut 
fracture is diagnosed and treated operatively as expedi. 
tiously as possible. 
4) Shiley Incorporated should continue to track surviving 
patients known ro have a Bjiirk-Shiley 60” Convexo- 
Concave valve implanted. Physicians should repat compli- 
cations. particularly the occurrcncc of outlet strut fracture, 
to the manufacturer. If the hazard function for outlet slrul 
fracture increases for a specific subset of palients or valves, 
then stronger consideration may be given for elective ea- 
plantation. 
5) Physicians who arc caring for patients who have had 
this prosthesis implanted should individualize the decision as 
to which patients should receive information regarding outlet 
strut fraciurc. It should be recognized that other valve&ad 
complicsdons are far more common than outler strut fracture. 
6) Difficulties in maintaining a medical device data base 
because of low rates of return of implant cards should be 
addressed by the industry and physicians to facilitate the 
return of useful information for analysis. 

